P2

General Information


DRACP ID  DRACP05751

Peptide Name   P2

Sequence  RGDGPRRRPRKRRGR

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Ahx, 6-aminohexamoic acid

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C74H138N40O18

Absent amino acids  ACEFHILMNQSTVWY

Common amino acids  R

Mass  212603

Pl  12.98

Basic residues  9

Acidic residues  1

Hydrophobic residues  0

Net charge  8

Boman Index  -13081

Hydrophobicity  -318.67

Aliphatic Index  0

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25459448

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2890

DRACP is developed by Dr.Zheng's team.